featured
Donanemab in Early Alzheimer's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Donanemab in Early Alzheimer's Disease
N. Engl. J. Med 2021 Mar 13;[EPub Ahead of Print], MA Mintun, AC Lo, C Duggan Evans, AM Wessels, PA Ardayfio, SW Andersen, S Shcherbinin, J Sparks, JR Sims, M Brys, LG Apostolova, SP Salloway, DM SkovronskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.